Fundamental dimension Equity attribute | CBBLFPeer $0.080.00% Cap $6.17MP/E -29.4x QuantScore28/100 | AURWFLeader $0.150.00% Cap $174.4KP/E -11.0x QuantScore39/100 | CSRVFPeer $0.37310.00% Cap $3.58MP/E -162.5x QuantScore29/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
53/100 |
45/100 |
64/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 33/100 | 23/100 |
Health Piotroski, Altman Z, leverage & liquidity | 25/100 | 26/100 | 29/100 |
Growth Revenue / earnings growth & margins | 0/100 | 50/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -29.4x | -11.0x | -162.5x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -67.2x | -14.8x | -23.1x |
Price / Sales | — | — | — |
Price / Free Cash Flow | -483.3x | -30.3x | -18.6x |
PEG ratio | 0.16 | 0.03 | 1.46 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 1 / 9 | 2 / 9 | 3 / 9 |
Altman Z-Score | -75.72 (Distress) | -14.30 (Distress) | 0.38 (Distress) |
Total debt / equity | -0.07 | 0.00 | 0.00 |
Quick ratio | 0.2x | 0.8x | 0.1x |
Interest coverage | — | — | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | — | — |
Net income growth YoY | -730.1% | +216.5% | -199.0% |
Gross margin (TTM) | 0.0% | 0.0% | 0.0% |
Operating margin (FY) | — | — | — |
FCF margin (FY) | — | — | — |
5. Trailing price performancePrice change over period |
1M return | 0.0% | 0.0% | +44.0% |
3M return | +83.1% | -46.4% | +31.4% |
6M return | +153.2% | -46.4% | +31.4% |
Year to date | +247.8% | -31.8% | +26.9% |
1Y return | +6566.7% | -92.5% | +122.1% |
3Y return | +700.0% | -85.0% | +24.4% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.0008 -101.0% premium | $-0.115 -176.6% premium | $0.0346 -90.7% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |